SynthesisCancer2026

Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm.

Salvatore Perrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.